Articles with public access mandates - sylvain marchand-adamLearn more
Not available anywhere: 4
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d'Etudes et de Recherche sur les …
V Cottin, E Bel, P Bottero, K Dalhoff, M Humbert, R Lazor, RA Sinico, ...
Autoimmunity reviews 16 (1), 1-9, 2017
Mandates: National Institute for Health Research, UK
Role of coagulation and fibrinolysis in lung and renal fibrosis
C Ruppert, P Markart, M Wygrecka, KT Preissner, A Günther
Hämostaseologie 28 (01/02), 30-36, 2008
Mandates: German Research Foundation
Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer
F Gueugnon, A Barascu, K Mavridis, A Petit-Courty, S Marchand-Adam, ...
Tumor Biology 36, 4979-4986, 2015
Mandates: Swiss Cancer League
A94 NEW INSIGHTS IN IPF: Contribution Of Mutations In Genes Encoding Proteins Of The Surfactant Metabolism To Idiopathic Interstitial Pneumonia And Idiopathic Pulmonary …
N Nathan, R Borie, C Kannengiesser, FD Le Moal, H Nunes, D Valeyre, ...
American Journal of Respiratory and Critical Care Medicine 193, 1, 2016
Mandates: National Institute of Health and Medical Research, France
Available somewhere: 32
Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis
N Riteau, P Gasse, L Fauconnier, A Gombault, M Couegnat, L Fick, ...
American journal of respiratory and critical care medicine 182 (6), 774-783, 2010
Mandates: National Institute of Health and Medical Research, France
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
PA Juge, JS Lee, E Ebstein, H Furukawa, E Dobrinskikh, S Gazal, ...
New England Journal of Medicine 379 (23), 2209-2219, 2018
Mandates: US Department of Defense, US National Institutes of Health
Methotrexate and rheumatoid arthritis associated interstitial lung disease
PA Juge, JS Lee, J Lau, L Kawano-Dourado, JR Serrano, M Sebastiani, ...
European Respiratory Journal 57 (2), 2021
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Therapeutic targeting of cathepsin C: from pathophysiology to treatment
B Korkmaz, GH Caughey, I Chapple, F Gauthier, J Hirschfeld, DE Jenne, ...
Pharmacology & therapeutics 190, 202-236, 2018
Mandates: German Research Foundation
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
A Fabre, J Marchal-Somme, S Marchand-Adam, C Quesnel, R Borie, ...
European Respiratory Journal 32 (2), 426-436, 2008
Mandates: National Institute of Health and Medical Research, France
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
CH Marquette, J Boutros, J Benzaquen, M Ferreira, J Pastre, C Pison, ...
The Lancet Respiratory Medicine 8 (7), 709-716, 2020
Mandates: Swiss Cancer League
B cell activating factor is central to bleomycin-and IL-17-mediated experimental pulmonary fibrosis
A François, A Gombault, B Villeret, G Alsaleh, M Fanny, P Gasse, ...
Journal of autoimmunity 56, 1-11, 2015
Mandates: Swiss National Science Foundation, National Institute of Health and Medical …
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
V Cottin, B Crestani, D Valeyre, B Wallaert, J Cadranel, JC Dalphin, ...
European Respiratory Review 23 (132), 193-214, 2014
Mandates: National Institute of Health and Medical Research, France
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
TM Maher, S Stowasser, Y Nishioka, ES White, V Cottin, I Noth, M Selman, ...
The Lancet respiratory medicine 7 (9), 771-779, 2019
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C
M Kasabova, A Joulin-Giet, F Lecaille, BF Gilmore, S Marchand-Adam, ...
Journal of Biological Chemistry 289 (23), 16239-16251, 2014
Mandates: National Institute of Health and Medical Research, France
Activation of somatostatin receptors attenuates pulmonary fibrosis
R Borie, A Fabre, F Prost, J Marchal-Somme, R Lebtahi, ...
Thorax 63 (3), 251-258, 2008
Mandates: National Institute of Health and Medical Research, France
Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease
L Gallay, Y Uzunhan, R Borie, R Lazor, P Rigaud, S Marchand-Adam, ...
American journal of respiratory and critical care medicine 203 (2), 245-249, 2021
Mandates: US Department of Defense, US National Institutes of Health
Neutrophilic cathepsin C is maturated by a multistep proteolytic process and secreted by activated cells during inflammatory lung diseases
Y Hamon, M Legowska, V Hervé, S Dallet-Choisy, S Marchand-Adam, ...
Journal of Biological Chemistry 291 (16), 8486-8499, 2016
Mandates: National Institute of Health and Medical Research, France, European Commission
Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases
C Guarino, Y Hamon, C Croix, AS Lamort, S Dallet-Choisy, ...
Biochemical pharmacology 131, 52-67, 2017
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases
G Lalmanach, A Saidi, S Marchand-Adam, F Lecaille, M Kasabova
Biological Chemistry 396 (2), 111-130, 2015
Mandates: National Institute of Health and Medical Research, France
New selective peptidyl di (chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases
C Guarino, M Legowska, C Epinette, C Kellenberger, S Dallet-Choisy, ...
Journal of Biological Chemistry 289 (46), 31777-31791, 2014
Mandates: National Institute of Health and Medical Research, France
Publication and funding information is determined automatically by a computer program